Optimization of an Antibody Light Chain Framework Enhances Expression, Biophysical Properties and Pharmacokinetics
Efficacy, safety, and manufacturability of therapeutic antibodies are influenced by their biopharmaceutical and biophysical properties. These properties can be optimized by library approaches or rationale protein design. Here, we employed a protein engineering approach to modify the variable domain...
Main Authors: | Patrice Douillard, Michael Freissmuth, Gerhard Antoine, Michael Thiele, Daniel Fleischanderl, Peter Matthiessen, Dirk Voelkel, Randolf J. Kerschbaumer, Friedrich Scheiflinger, Nicolas Sabarth |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4468/8/3/46 |
Similar Items
-
Chlamydophila pneumoniae serological epidemiology
by: Salvatore Pignanelli, et al.
Published: (2010-06-01) -
Identifying biophysical assays and in silico properties that enrich for slow clearance in clinical-stage therapeutic antibodies
by: Boris Grinshpun, et al.
Published: (2021-01-01) -
Pharmacokinetics of Human Recombinant Anti-Botulinum Toxin Antibodies in Rats
by: Yero Espinoza, et al.
Published: (2019-06-01) -
Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human framework
by: Romain Ollier, et al.
Published: (2023-12-01) -
Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in mice
by: Shufang Liu, et al.
Published: (2023-12-01)